PROCESS FOR MANUFACTURING PHARMACEUTICAL COMPOSITION COMPRISES OF MYCOBACTERIUM W IN THE TREATMENT OF BRONCHIAL ASTHMA ATTACK
Application 247/MUM/2002 published 2006-09-01, filed 2002-03-13
The process of manufacturing a pharmaceutical composition for the management of asthma (obstructive lung disease) comprises of incorporating cells of mycobacterium w along with pharmaceutically acceptable carrier and optionally a preservative in a single formulation. Drawing: NIL Total Pages: 20 Fig. Nil
Applicant
CADILA PHARMACEUTICALS LTD.
“CADILA CORPORATE CAMPUS”, SARKHEJ-DHOLKA ROAD, BHAT, AHMEDABAD, 382210, GUJARAT, INDIA
Inventor
1. DR RAJIV I. MODI 2. DR. BAKULESH MAFATLAL KHAMAR
International Info
Classification: C07D 473/00, A61K 31/00